BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37681334)

  • 1. Bulk RNA-Seq Combined with Single-Cell Transcriptome Sequencing Reveals the Possible Mechanisms by Which HDGFL3 Involves in Prostate Cancer Growth and Metastasis.
    Xiao C; Liang W
    Arch Esp Urol; 2023 Aug; 76(6):425-438. PubMed ID: 37681334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.
    Heidegger I; Fotakis G; Offermann A; Goveia J; Daum S; Salcher S; Noureen A; Timmer-Bosscha H; Schäfer G; Walenkamp A; Perner S; Beatovic A; Moisse M; Plattner C; Krogsdam A; Haybaeck J; Sopper S; Thaler S; Keller MA; Klocker H; Trajanoski Z; Wolf D; Pircher A
    Mol Cancer; 2022 Jun; 21(1):132. PubMed ID: 35717322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer].
    Yang M; Zhu X; Shen Y; He Q; Qin Y; Shao Y; Yuan L; Ye H
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1109-1118. PubMed ID: 36073208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of WNT10B in normal prostate gland development and prostate cancer.
    Madueke I; Hu WY; Hu D; Swanson SM; Vander Griend D; Abern M; Prins GS
    Prostate; 2019 Oct; 79(14):1692-1704. PubMed ID: 31433503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
    Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
    Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
    Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA.
    Mao S; Zhang W; Yang F; Guo Y; Wang H; Wu Y; Wang R; Maskey N; Zheng Z; Li C; Ma W; Zhang J; Yan Y; Yao X
    J Exp Clin Cancer Res; 2021 Oct; 40(1):336. PubMed ID: 34696782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptonide acts as a novel antiprostate cancer agent mainly through inhibition of mTOR signaling pathway.
    Dong F; Yang P; Wang R; Sun W; Zhang Y; Wang A; Chen M; Chen L; Zhang C; Jiang M
    Prostate; 2019 Aug; 79(11):1284-1293. PubMed ID: 31212374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
    Zhang X; Wang Y; Ning Y
    Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
    Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients.
    Belluti S; Semeghini V; Rigillo G; Ronzio M; Benati D; Torricelli F; Reggiani Bonetti L; Carnevale G; Grisendi G; Ciarrocchi A; Dominici M; Recchia A; Dolfini D; Imbriano C
    J Exp Clin Cancer Res; 2021 Nov; 40(1):362. PubMed ID: 34782004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating single-cell and bulk RNA sequencing to predict prognosis and immunotherapy response in prostate cancer.
    Wen XY; Wang RY; Yu B; Yang Y; Yang J; Zhang HC
    Sci Rep; 2023 Sep; 13(1):15597. PubMed ID: 37730847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4 Expressed by Tumor-Infiltrating B Cells in Gastric Cancer Related to Survival in the Tumor Microenvironment: An Analysis Combining Single-Cell RNA Sequencing with Bulk RNA Sequencing.
    Su C; Yu R; Hong X; Zhang P; Guo Y; Cai JC; Hou J
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircLRP6 contributes to prostate cancer growth and metastasis by binding to miR-330-5p to up-regulate NRBP1.
    Qin L; Sun X; Zhou F; Liu C
    World J Surg Oncol; 2021 Jun; 19(1):184. PubMed ID: 34158077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TWIST2: A new candidate tumor suppressor in prostate cancer.
    Zhao C; Zhang W; Zhu X; Xu Y; Yang K; Wei D; Liang S; Zhao F; Zhang Y; Chen X; Sun L; Yuan H; Shi X; Wang X; Liu M; Yang F; Wang J; Yang Z
    Prostate; 2019 Oct; 79(14):1647-1657. PubMed ID: 31433071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor network analysis based on single cell RNA-seq identifies that Trichostatin-a reverses docetaxel resistance in prostate Cancer.
    Schnepp PM; Ahmed A; Escara-Wilke J; Dai J; Shelley G; Keller J; Mizokami A; Keller ET
    BMC Cancer; 2021 Dec; 21(1):1316. PubMed ID: 34879849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
    Xue D; Lu H; Xu HY; Zhou CX; He XZ
    J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTSS1 hypermethylation is associated with prostate cancer progression.
    Chen J; Huang L; Zhu Q; Wang Z; Tang Z
    J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.